Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory infections among infants, particularly ...

Scientists have uncovered strong evidence that infection with RSV in the first months of life can significantly raise the ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

Scientists found that RSV infection early in life can set the stage for childhood asthma, particularly in kids already genetically prone to allergies. The virus appears to skew the developing immune ...

Globally, RSV causes millions of respiratory infections each year and is responsible for a large proportion of ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. MAURICE, La. (KLFY) — A virus often mistaken ...

Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection ...

For infants less than 8 months of age born during or entering their first RSV season and not otherwise protected through maternal vaccination, nirsevimab is considered the first-line recommended ...

Credit: Getty Images. The BLA acceptance was supported by data from the randomized, placebo-controlled phase 2b/3 CLEVER trial as well as interim data from the ongoing phase 3 SMART trial. A ...

Like the flu and COVID, the symptoms of a cold are often coughing, a sore throat, tiredness and sometimes a fever. However, ...